According to the research report, the global clinical laboratory services market size is expected to touch USD 293.6 Billion by 2030, from USD 213.8 Billion in 2022, growing with a significant CAGR of 4.04% from 2022 to 2030.
The clinical laboratory services report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global clinical laboratory services in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global clinical laboratory services market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global clinical laboratory services during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1627
| Report Coverage | Details |
| Market Size by 2030 | USD 293.6 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 4.04% |
| North America Market Share in 2021 | 41% |
| Clinical Chemistry Market Share in 2021 | 52% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Test Type, Service Provider, Application, Geography |
This study covers a detailed segmentation
of the global clinical laboratory services market, along with key information
and a competition outlook. The report mentions company profiles of players that
are currently dominating the global clinical laboratory services market,
wherein various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Charles River Laboratories International Inc.
- Laboratory Corporation of America Holdings
- NeoGenomics Laboratories Inc.
- Siemens Healthcare GmbH
- Quest Diagnostics Inc.
- Fresenius Medical Care
- Viapath Group LLP
- Almac Group
- Sonic Healthcare
- OPKO Health Inc.
Market Segmentation
- Human and Tumor Genetics
- Clinical Chemistry
- Medical Microbiology and Cytology
- Genetic Testing
- Drug of Abuse Testing
- Other Esoteric Tests
By Service Provider
- Hospital based laboratories
- Standalone laboratories
- Clinic based laboratories
By Application
- Bioanalytical and Lab Chemistry Services
- Toxicology Testing Services
- Cell and Gene Therapy Related Services
- Preclinical and Clinical Trial Related Services
- Drug Discovery and Development Related Services
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global clinical laboratory services report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global clinical laboratory services market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Laboratory Services Market
5.1. COVID-19 Landscape: Clinical Laboratory Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Laboratory Services Market, By Test Type
8.1. Clinical Laboratory Services Market, by Test Type Type, 2022-2030
8.1.1. Human and Tumor Genetics
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Clinical Chemistry
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Medical Microbiology and Cytology
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Genetic Testing
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Drug of Abuse Testing
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Other Esoteric Tests
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Clinical Laboratory Services Market, By Application
9.1. Clinical Laboratory Services Market, by Application, 2022-2030
9.1.1. Bioanalytical and Lab Chemistry Services
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Toxicology Testing Services
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cell and Gene Therapy Related Services
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Preclinical and Clinical Trial Related Services
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Drug Discovery and Development Related Services
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Clinical Laboratory Services Market, By Service Provider
10.1. Clinical Laboratory Services Market, by Service Provider, 2022-2030
10.1.1. Hospital based laboratories
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Standalone laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Clinic based laboratories
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Clinical Laboratory Services Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Service Provider (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Service Provider (2017-2030)
Chapter 12. Company Profiles
12.1. Charles River Laboratories International Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Laboratory Corporation of America Holdings
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. NeoGenomics Laboratories Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Siemens Healthcare GmbH
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Quest Diagnostics Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Fresenius Medical Care
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Viapath Group LLP
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Almac Group
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Sonic Healthcare
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. OPKO Health Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments